Skip to content

1C70 Feasibility Study

Prospective, Feasibility Study to Evaluate Performance, Patient Benefits, and Acceptance of a New 1C70 Energy Storage and Return Prosthetic Foot

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05628064
Enrollment
22
Registered
2022-11-28
Start date
2022-11-24
Completion date
2023-06-28
Last updated
2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation

Keywords

amputation, transtibial, prosthetic foot

Brief summary

The objective of this study is to characterize the extent of 1C70 meeting the amputees needs in comparison with their everyday and a comparator foot, in regards of daily activities, mobility and balance, as well as quality of life and pain.

Interventions

DEVICE1C70

Investigational energy storage and return prosthetic foot with using novel elastic elements.

DEVICEPro-Flex XC

Commercially available carbon-fiber energy storage and return foot used as comparative foot for transtibial amputee subjects.

Sponsors

Ottobock SE & Co. KGaA
CollaboratorUNKNOWN
Otto Bock Healthcare Products GmbH
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized cross-over controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Person is at least 18 years old. * Person is a unilateral transtibial amputee with stabilized residual limb. * Person is a K3 ambulator based on Medicare Functional Classification Level (MFCL) . * Person has at least 6 months experience in walking with a prosthesis. * Person is using an energy storage and return (ESR) foot as their primary everyday foot * Person has a foot size between 22 and 30. * Person weights with a prosthesis between 50 and 125 kg (foot size 26 - 30), or between 45 and 100 kg (foot size 22 - 25). * Person wears a prosthesis daily and ≥ 8 hours/day. * Person is able to walk at least 500 m without having to make a break. * Person is willing and able to independently provide informed consent. * Person is willing to comply with study procedures.

Exclusion criteria

* Person is pregnant. * Person is using a hydraulic foot as their primary everyday foot. * Person is using a sport foot (e.g., Fillauer AllPro, Ottobock Challenger, Össur Flex-Foot Cheetah) as their primary everyday foot. * Person is using an ESR foot with an integrated vacuum pump (e.g., Ottobock 1C62 Triton Harmony). * Person has conditions that would prevent participation and pose increased risk (e.g., unstable cardiovascular conditions that preclude physical activity such as walking). * Person falls ≥ once a week due to the reasons that are not related to prosthesis (e.g., problems with vestibular system). * Person is not available for study visits during planned study duration. * Person is participating in another study or intends to participate in another study during this study´s duration. * Person cannot personally provide their consent.

Design outcomes

Primary

MeasureTime frameDescription
Extent of meeting amputees prosthetic foot needs: 1C70 vs everyday foot2 months after fitting with the last study feetThe extent of meeting amputees prosthetic foot needs by 1C70 as measured by a single question with a 0 to 10 scale compared to the same score for everyday foot. Higher score correspond with higher extent of meeting amputees prosthetic foot needs.
Extent of meeting amputees prosthetic foot needs: 1C70 vs comparator foot2 months after fitting with the last study feetThe extent of meeting amputees prosthetic foot needs by 1C70 as measured by a single question with a 0 to 10 scale compared to the same score for comparator foot. Higher score correspond with higher extent of meeting amputees prosthetic foot needs.
Change in patient-perceived mobility (PLUS-M) compared to baselineBaseline measurement vs 2 months after fitting with 1C70The change from baseline perception of mobility as measured by the Prosthetic Limb Users Survey of Mobility (PLUS-M) 12-item short form. The PLUS-M questionnaire provides a T-score that ranges from 21.8 to 71.4. Higher PLUS-M scores correspond with greater mobility.
Change in patient-perceived mobility (PLUS-M) compared to the comparator foot2 months after fitting with each of the study feetThe change from baseline perception of mobility as measured by the Prosthetic Limb Users Survey of Mobility (PLUS-M) 12-item short form. The PLUS-M questionnaire provides a T-score that ranges from 21.8 to 71.4. Higher PLUS-M scores correspond with greater mobility.
Highest pain reported: 1C70 vs everyday footBaseline measurement vs 2 months after fitting with 1C70The level of pain as a highest pain during preceding 7 days reported on a 0 (No pain at all) to 10 (the most intense pain imaginable) scale for the following origins: residual limb, sound limb, back, shoulder & neck area, phantom limb pain, while wearing the 1C70 foot compared to the everyday foot.
Highest pain reported: 1C70 vs comparator foot2 months after fitting with each of the study feetThe level of pain as a highest pain during preceding 7 days reported on a 0 (No pain at all) to 10 (the most intense pain imaginable) scale for the following origins: residual limb, sound limb, back, shoulder & neck area, phantom limb pain, while wearing the 1C70 foot compared to the coparator foot.

Other

MeasureTime frameDescription
Change in patient perceived balance confidence (ABC) compared to baseline: 1C70 vs everyday footBaseline measurement vs 2 months after fitting with 1C70Perception of balance confidence as measured by the Activities-specific Balance Confidence (ABC) Scale. The questionnaire provides a score that ranges from 0 to 100%. Higher scores indicate greater balance confidence.
Foot preference overall and for use in several specific activities2 months after fitting with the last study feetFoot preference overall and for use in several specific activities as measured by a questionnaire from the publication of Morgan et al. (Morgan et al. 2018)
Change in patient perceived balance confidence (ABC) compared to baseline: 1C70 vs comparator foot2 months after fitting with each of the study feetPerception of balance confidence as measured by the Activities-specific Balance Confidence (ABC) Scale. The questionnaire provides a score that ranges from 0 to 100%. Higher scores indicate greater balance confidence.
Quality of life as measured by the EQ-5D-5L: 1C70 vs everyday footBaseline measurement vs 2 months after fitting with 1C70Measure of health status composed of 5 dimensions: mobility, ability to self-care, ability to undertake usual activities, pain and discomfort, anxiety and depression. Each dimension is rated on a 5-point scale indicating the level of perceived problems for each dimension (level 1 indicating no problems and level 5 indicating extreme problems). Each health state can potentially be assigned a summary index score based on societal preference weights for the health state. These weights, sometimes referred to as 'utilities', are often used to compute QALYs for use in health economic analyses. Health state index scores generally range from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.
Quality of life as measured by the EQ-5D-5L: 1C70 vs comparator foot2 months after fitting with each of the study feetMeasure of health status composed of 5 dimensions: mobility, ability to self-care, ability to undertake usual activities, pain and discomfort, anxiety and depression. Each dimension is rated on a 5-point scale indicating the level of perceived problems for each dimension (level 1 indicating no problems and level 5 indicating extreme problems). Each health state can potentially be assigned a summary index score based on societal preference weights for the health state. These weights, sometimes referred to as 'utilities', are often used to compute QALYs for use in health economic analyses. Health state index scores generally range from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.
Pain interference: 1C70 vs everyday footBaseline measurement vs 2 months after fitting with 1C70Perception of pain interference on the usual activities as measured by a single question with a 0 (Does not interfere) to 10 (Completely interferes) scale.
Pain interference: 1C70 vs comparator foot2 months after fitting with each of the study feetPerception of pain interference on the usual activities as measured by a single question with a 0 (Does not interfere) to 10 (Completely interferes) scale.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026